title: Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis.
authors.affiliation: Department of Neuroscience, Queen Mary University of London, London, UK.
authors.forename: Gareth
authors.initials: G
authors.lastname: Pryce
authors.affiliation: Department of Neuroscience, Queen Mary University of London, London, UK.
authors.forename: David
authors.initials: D
authors.lastname: Baker
mesh_terms: D003362:Cost-Benefit Analysis; D013759:Dronabinol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D019057:Quality-Adjusted Life Years
chemical_list: D013759:Dronabinol